The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Consensus Panel Recommendations for the Pharmacological Management of Pregnant Women with Depressive Disorders
Open accessAbstract
Introduction: The initiative of a consensus on the topic of antidepressant and anxiolytic drug use in pregnancy is developing in an area of clinical uncertainty. Although many studies have been published in recent years, there is still a paucity of authoritative evidence-based indications useful for guiding the prescription of these drugs during pregnancy, and the data from the literature are complex and require expert judgment to draw clear conclusions. Methods: For the elaboration of the consensus, we have involved the scientific societies of the sector, namely, the Italian Society of Toxicology, the Italian Society of Neuropsychopharmacology, the Italian Society of Psychiatry, the Italian Society of Obstetrics and Gynecology, the Italian Society of Drug Addiction and the Italian Society of Addiction Pathology. An interdisciplinary team of experts from different medical specialties (toxicologists, pharmacologists, psychiatrists, gynecologists, neonatologists) was first established to identify the needs underlying the consensus. The team, in its definitive structure, includes all the representatives of the aforementioned scientific societies; the task of the team was the evaluation of the most accredited international literature as well as using the methodology of the “Nominal Group Technique” with the help of a systematic review of the literature and with various discussion meetings, to arrive at the drafting and final approval of the document. Results: The following five areas of investigation were identified: (1) The importance of management of anxiety and depressive disorders in pregnancy, identifying the risks associated with untreated maternal depression in pregnancy. (2) The assessment of the overall risk of malformations with the antidepressant and anxiolytic drugs used in pregnancy. (3) The evaluation of neonatal adaptation disorders in the offspring of pregnant antidepressant/anxiolytic-treated women. (4) The long-term outcome of infants’ cognitive development or behavior after in utero exposure to antidepressant/anxiolytic medicines. (5) The evaluation of pharmacological treatment of opioid-abusing pregnant women with depressive disorders. Conclusions: Considering the state of the art, it is therefore necessary in the first instance to frame the issue of pharmacological choices in pregnant women who need treatment with antidepressant and anxiolytic drugs on the basis of data currently available in the literature. Particular attention must be paid to the evaluation of the risk/benefit ratio, understood both in terms of therapeutic benefit with respect to the potential risks of the treatment on the pregnancy and on the fetal outcome, and of the comparative risk between the treatment and the absence of treatment; in the choice prescription, the specialist needs to be aware of both the potential risks of pharmacological treatment and the equally important risks of an untreated or undertreated disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, three guidelines offered explicit advice to use agents such as lorazepam, temazepam, oxazepam or brotizolam, which either undergo limited hepatic metabolism or have relatively shorter elimination half-lives to minimise theoretic fetal or lactational exposure.32,34,55”
From Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review (2024) · cites this paper as [32]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately 20 to 40% of neonates who have been exposed to BZDs in utero during late pregnancy develop neonatal withdrawal, with symptoms including irritability, increased sedation, abnormal muscle tone, poor feeding, sleep problems, and mild respiratory distress.179–183”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [181]
In the citing paper
“BZD treatment specifications were provided more often in the context of perinatal/post-partum depressive disorders.32,34,55”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–262 of 262
Retentissement néonatal de l'exposition aux benzodiazépines en fin de grossesse
Swortfiguer, D., Cissoko, H., Giraudeau, B., Jonville-Béra, A. P., Bensouda, L., & Autret-Leca, E. (2005) · Archives de Pédiatrie · doi:10.1016/j.arcped.2005.03.055 · Cited by 43
Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
Klinger, G., & Merlob, P. (2008) · PubMed · Cited by 43
Boucher, N., Koren, G., & Beaulac-Baillargeon, L. (2009) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3181a58fb4 · Cited by 42
Knudsen, T. M., Hansen, A. V., Garne, E., & Andersen, A. N. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-333 · Cited by 42
Wang, X., Zhang, T., Ekheden, I. G., Chang, Z., Hellner, C., Hasselström, J., Jayaram‐Lindström, N., D'Onofrio, B. M., Larsson, H., Mataix‐Cols, D., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104647 · Cited by 42
Viktorin, A., Lichtenstein, P., Lundholm, C., Almqvist, C., D'Onofrio, B. M., Larsson, H., Landén, M., & Magnusson, P. K. E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv351 · Cited by 41
Liu, X., Molenaar, N. M., Agerbo, E., Momen, N. C., Rommel, A., Lupattelli, A., Bergink, V., & Munk‐Olsen, T. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003895 · Cited by 39
Chang, Q., Ma, X., Xu, X., Su, H., Wu, Q., & Zhao, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00659 · Cited by 36
Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis
Lohr, W. D., Wanta, J. W., Baker, M., Grudnikoff, E., Morgan, W. S., Chhabra, D., & Lee, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642798 · Cited by 36
Gestational Exposure to Antidepressants and the Risk of Spontaneous Abortion: A Review
Broy, P., & Bérard, A. (2010) · Current Drug Delivery · doi:10.2174/156720110790396508 · Cited by 35
Pregnancy Outcome Following Maternal Exposure to Mirtazapine: A Multicenter, Prospective Study
Winterfeld, U., Klinger, G., Panchaud, A., Stephens, S., Arnon, J., Malm, H., te Winkel, B., Clementi, M., Pistelli, A., Maňáková, E., et al. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000309 · Cited by 34
Self-citationSkalkidou, A., Poromaa, I. S., Wikman, A., Hesselman, S., Wikström, A., & Elenis, E. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16210 · Cited by 34
Dandjinou, M., Sheehy, O., & Bérard, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025908 · Cited by 33
Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016) · Drug Safety · doi:10.1007/s40264-016-0435-8 · Cited by 32 · cited 2×
“The onset and duration of symptoms correlate with the pharmacokinetics and placental disposition of benzodiazepines [227].”
BackgroundOgawa, Y., Takeshima, N., & Furukawa, T. A. (2018) · Asia-Pacific Psychiatry · doi:10.1111/appy.12309 · Cited by 32
Antidepressant use in pregnancy and severe cardiac malformations: Danish register‐based study
Kolding, L., Ehrenstein, V., Pedersen, L. H., Sandager, P., Petersen, O. B., Uldbjerg, N., & Pedersen, L. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16772 · Cited by 32
Rommel, A., Momen, N. C., Molenaar, N. M., Agerbo, E., Bergink, V., Munk‐Olsen, T., & Liu, X. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13409 · Cited by 32
Lupattelli, A., Wood, M. E., Lapane, K. L., Spigset, O., & Nordeng, H. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4286 · Cited by 31
Ankarfeldt, M. Z., Petersen, J., Andersen, J. T., Li, H., Motsko, S. P., Fast, T., Hede, S. M., & Jimenez‐Solem, E. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003851 · Cited by 31
Colvin, L., Slack-Smith, L. M., Stanley, F. J., & Bower, C. I. (2012) · CNS Drugs · doi:10.2165/11634190-000000000-00000 · Cited by 30
Chen, V. C., Wu, S., Lin, C.-F., Lu, M., Chen, Y., & Stewart, R. J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.43282 · Cited by 29
Richardson, J. L., Martin, F. Z., Dunstan, H. J., Greenall, A. J., Stephens, S., Yates, L. M., & Thomas, S. H. L. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.01.003 · Cited by 28
Howard, A. L., Kennedy, T. M., Macdonald, E. P., Mitchell, J. T., Sibley, M. H., Roy, A., Arnold, L. E., Epstein, J. N., Hinshaw, S. P., Hoza, B., et al. (2019) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-019-00573-y · Cited by 28
Latendresse, G., & Ruiz, R. J. (2011) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2010.00023.x · Cited by 27
Dao, K., Shechtman, S., Diav‐Citrin, O., George, N., Richardson, J. L., Rollason, V., Pistelli, A., Eleftheriou, G., Berlin, M., Ekobena, P., et al. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001630 · Cited by 27
Self-citationPregnancy and birth complications among mentally ill and well mothers and their children
Cohler, B. J., Gallant, D. H., Grunebaum, H. U., Weiss, J. L., & Gamer, E. (1975) · Social Biology · doi:10.1080/19485565.1975.9988176 · Cited by 26
Miyagawa, K., Tsuji, M., Ishii, D., Takeda, K., & Takeda, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.052 · Cited by 26
Şahingöz, M., Yüksel, G., Karşıdağ, Ç., Uğuz, F., Sönmez, E. Ö., Annagür, B. B., & Annagür, A. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000077 · Cited by 26
Fetal safety of methylphenidate-A scoping review and meta analysis
Koren, G., Barer, Y., & Ornoy, A. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.03.003 · Cited by 26
Wilens, T. E., Woodward, D. W., Ko, J. D., Berger, A. F., Burke, C., & Yule, A. M. (2022) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0016 · Cited by 26 · cited 1×
“Eventually, there is a possible link between childhood attention-deficit/hyperactivity disorder (ADHD) and substance abuse and depression [258], and pharmacological treatments for psychiatric disorders appear to mitigate the development of substance use disorders [259].”
BackgroundWurst, K., Zedler, B. K., Joyce, A. R., Sasinowski, M., & Murrelle, E. L. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s38887 · Cited by 25
Grieb, Z. A., & Ragan, C. M. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.239 · Cited by 24
Alwan, S., Bandoli, G., & Chambers, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.376 · Cited by 23
Mirtazapine in Pregnancy and Lactation: Data From a Case Series
Smit, M., Wennink, H. J. M. B., Heres, M., Dolman, K. M., & Honig, A. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000279 · Cited by 23
Grigoriadis, S., Al-Ibrahim, A., Mansfield, J. K., Sullovey, A., & Robinson, G. E. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13441 · Cited by 23
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
Corti, S., Pileri, P., Mazzocco, M. I., Mandò, C., Moscatiello, A. F., Cattaneo, D., Cheli, S., Baldelli, S., Pogliani, L., Clementi, E., et al. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00309 · Cited by 22
Prediction and Prevention of Spontaneous Preterm Birth
(2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004480 · Cited by 22
Andrade, C. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22f14593 · Cited by 22
Petrich, M. R., Battin, M., Walker, E., Brown, M. D., Abdelwahab, M., Ma’ayeh, M., & Rood, K. M. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2130238 · Cited by 20
Lou, Z., Zhou, Y., Zhang, X., & Jiang, H. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114756 · Cited by 19
Hale, T. W., Kendall-Tackett, K. A., Cong, Z., Votta, R., & McCurdy, F. A. (2010) · Breastfeeding Medicine · doi:10.1089/bfm.2010.0011 · Cited by 18
Antidepressant continuation in pregnancy and risk of gestational diabetes
Wartko, P. D., Weiss, N. S., Enquobahrie, D. A., Chan, K. C. G., Stephenson‐Famy, A., Mueller, B. A., & Dublin, S. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4799 · Cited by 18
Lupattelli, A., Barone‐Adesi, F., & Nordeng, H. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5388 · Cited by 17
Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
Vignato, J. A., Gumusoglu, S. B., Davis, H., Scroggins, S. M., Hamilton, W. S., Brandt, D. S., Pierce, G. L., Knosp, B. M., Santillan, D. A., & Santillan, M. K. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01065-z · Cited by 17
Assessment of Congenital Anomalies in Infants Born to Pregnant Women Enrolled in Clinical Trials
Rasmussen, S. A., Hernández–Dı́az, S., Abdul-Rahman, O. A., Şahin, L., Petrie, C. R., Keppler‐Noreuil, K. M., Frey, S. E., Mason, R. M., Nesin, M., & Carey, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu738 · Cited by 16
The psychological factor in spontaneous abortion
Michel-Wolfromm, H. (1968) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(68)90010-x · Cited by 16
Vigod, S. N., & Dennis, C. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.1430 · Cited by 15
Viguera, A. C., McElheny, S. A., Caplin, P. S., Kobylski, L. A., Rossa, E. T., Young, A. V., Gaccione, P., Góez-Mogollón, L. M., Freeman, M. P., & Cohen, L. S. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22m14492 · Cited by 15
Hendson, L., Shah, V. S., & Trkulja, S. (2021) · Paediatrics & Child Health · doi:10.1093/pch/pxab021 · Cited by 14
Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn
Sharma, M., Callan, E., & Konduri, G. G. (2022) · Clinics in Perinatology · doi:10.1016/j.clp.2021.11.010 · Cited by 13
Risk of cardiovascular malformations after exposure to paroxetine in pregnancy: meta-analysis
Painuly, N., Painuly, R., Heun, R., & Sharan, P. (2013) · The Psychiatrist · doi:10.1192/pb.bp.111.035915 · Cited by 12
Melov, S. J., Shetty, P., Pasupathy, D., Kirby, A. C., Sholler, G. F., Winlaw, D. S., & Alahakoon, T. I. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5846 · Cited by 11
Association of citalopram with congenital anomalies: A meta-analysis
Kang, H.-H., Ahn, K. H., Hong, S., Kwon, B. Y., Lee, E. H., Lee, J. S., Oh, M., & Kim, H.-J. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.2.145 · Cited by 10
Szpunar, M. J., Freeman, M. P., Kobylski, L. A., Caplin, P. S., Gaccione, P., Viguera, A. C., Chitayat, D. A., Hernández–Díaz, S., & Cohen, L. S. (2022) · Depression and Anxiety · doi:10.1002/da.23280 · Cited by 10
Bias against the null hypothesis: scaring pregnant women about drugs in pregnancy.
Koren, G., Madjunkova, S., & Maltepe, C. (2014) · PubMed · Cited by 8
Munk‐Olsen, T., Bergink, V., Rommel, A., Momen, N. C., & Liu, X. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.36639 · Cited by 8
Shea, A. K., Wang, D. Y., Snelgrove, J. W., Dalfen, A., Hewko, S. L., & Murphy, K. E. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.09.026 · Cited by 6
Safety of SSRIs during pregnancy: a controlled study
Altamura, A., Gaspari, I. D., Rovera, C., Colombo, E., Mc, M., & Fedele, L. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2276 · Cited by 5
Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi, S., Amato, L., Jahanfar, S., Bellisario, C., Ferri, M., & Davoli, M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub4 · Cited by 4
Love, T., Shabalin, A. A., Kember, R. L., Docherty, A. R., Zhou, H., Koppelmans, V., Gelernter, J. E., Baker, A. K., Hartwell, E. E., Dubroff, J. G., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01325-1 · Cited by 3
Eleftheriou, G., FIOCCHI, R., Butera, R., Giampreti, A., Mangili, G., & Delfina, M. (2017) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2017/34620 · Cited by 1
Self-citationMaintenance treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., & Vecchi, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318 · Cited by 1
Research works printed but not linked: 1
- Schloemp, 2006, Congenital malformations after antidepressant medication with paroxetine in early pregnancy?, Hum. Reprod., 21, i12
Cited by
Vigod, S. N., Frey, B. N., Clark, C. T., Grigoriadis, S., Barker, L. C., Brown, H. K., Charlebois, J., Dennis, C., Fairbrother, N., Green, S. M., et al. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241303031 · Cited by 113
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Brunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
Eleftheriou, G., Callegher, R. Z., Butera, R., Santis, M. D., Cavaliere, A. F., Vecchio, S., Lanzi, C., Davanzo, R., Mangili, G., Bondi, E., et al. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050551 · Cited by 36
Self-citationManagement of Bipolar Disorder in Pregnancy and Postpartum: A Clinicians’ Guide
Bergink, V., Suleiman, M., Hennen, M., & Robakis, T. K. (2025) · CNS Drugs · doi:10.1007/s40263-025-01202-7 · Cited by 13
Metadata
- Authors
- Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., Gallo, M., Balestrieri, M., & Albert, U.
- Affiliations
- Ospedale Papa Giovanni XXIII (IT)
- Italian Society of Psychiatry (SIP), piazza Santa Maria della Pietà 5, 00135 Rome, Italy
- Italian Society of Obstetrics and Gynecology (SIGO), via di Porta Pinciana 6, 00187 Rome, Italy
- Italian Society of Toxicology (SITOX), via Giovanni Pascoli 3, 20129 Milan, Italy
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Ser.D Biella—Drug Addiction Service, 13875 Biella, Italy
- University of Udine (IT)
- University of Trieste (IT)
- Corresponding author
- Eleftheriou, Georgios
- ORCID
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2023-08-11
- Volume
- 20
- Issue
- 16
- Pages
- 6565
- ISSN
- 1660-4601 (ISSN-L)
- PMC
- PMC10454549
- OpenAlex
- W4385759437
- Cited by
- 17
- References
- 262
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 2
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- antidepressant use in pregnancy, fetal malformations, infant cognitive development, opioid use disorder in pregnancy, risk-benefit assessment, consensus recommendations, prenatal drug exposure, neonatal abstinence syndrome, maternal and fetal outcomes
- MeSH terms
- Clinical Decision-Making, Depressive Disorder, Female, Humans, Infant, Infant, Newborn, Pregnancy, Psychiatry, Anti-Anxiety Agents, Uncertainty, Pregnant People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.